These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34247095)

  • 21. Common variable immunodeficiency: two mutations are better than one.
    La Cava A
    J Clin Invest; 2013 Oct; 123(10):4142-3. PubMed ID: 24051372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
    Waldrep ML; Zhuang Y; Schroeder HW
    BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
    Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C
    Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.
    Pulvirenti F; Zuntini R; Milito C; Specchia F; Spadaro G; Danieli MG; Pession A; Quinti I; Ferrari S
    J Immunol Res; 2016; 2016():8390356. PubMed ID: 27123465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TACI is mutant in common variable immunodeficiency and IgA deficiency.
    Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
    Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
    Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of TACI signaling on humoral immunity and autoimmune diseases.
    Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
    J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TACI, isotype switching, CVID and IgAD.
    Castigli E; Geha RS
    Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).
    Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R
    J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
    Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
    J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations.
    Freiberger T; Ravčuková B; Grodecká L; Pikulová Z; Stikarovská D; Pešák S; Kuklínek P; Jarkovský J; Salzer U; Litzman J
    Hum Immunol; 2012 Nov; 73(11):1147-54. PubMed ID: 22884984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
    Ou X; Xu S; Lam KP
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential induction of plasma cells by isoforms of human TACI.
    Garcia-Carmona Y; Cols M; Ting AT; Radigan L; Yuk FJ; Zhang L; Cerutti A; Cunningham-Rundles C
    Blood; 2015 Mar; 125(11):1749-58. PubMed ID: 25631768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune manifestations in common variable immunodeficiency.
    Cunningham-Rundles C
    J Clin Immunol; 2008 May; 28 Suppl 1(Suppl 1):S42-5. PubMed ID: 18322785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
    Berglund LJ; Jones GJ; Murali R; Fulcher DA
    J Allergy Clin Immunol; 2006 Apr; 117(4):870-7. PubMed ID: 16630947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.
    Bacchelli C; Buckridge S; Thrasher AJ; Gaspar HB
    Clin Exp Immunol; 2007 Sep; 149(3):401-9. PubMed ID: 17697196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TACI haploinsufficiency protects against BAFF-driven humoral autoimmunity in mice.
    Jacobs HM; Arkatkar T; Du SW; Scharping NE; Woods J; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Eur J Immunol; 2021 Sep; 51(9):2225-2236. PubMed ID: 34146342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.
    Salzer U; Grimbacher B
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):496-503. PubMed ID: 16264328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
    Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P
    Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood.
    Barroeta Seijas AB; Graziani S; Cancrini C; Finocchi A; Ferrari S; Miniero R; Conti F; Zuntini R; Chini L; Chiarello P; Bengala M; Rossi P; Moschese V; Di Matteo G
    Int J Immunopathol Pharmacol; 2012; 25(2):407-14. PubMed ID: 22697072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.